Aminoquinazolines which inhibit signal transduction mediated by tyrosine kinases

US6656946B2 · kind B2 · utility

Assignee

• BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG · DE

Inventors

• Frank Himmelsbach · Mittelbiberach, DE
• Elke Langkopf · Biberach an der Riß, DE
• Birgit Jung · Laupheim, DE
• Stefan Blech · Warthausen, DE
• Flavio Solca · Wien, AT

Key dates

• Filing date: Aug 22, 2001
• Grant date: Dec 2, 2003
• Expiry date: Aug 22, 2021

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D413/14
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Compounds of the formula having an inhibitory effect on signal transduction mediated by tyrosine kinases and their use in the treatment of diseases, especially tumoral diseases and diseases of the lungs and airways, and the preparation thereof.